Cargando…

Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study

BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeki...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, John, Wilson, Trevor, Gruhl, Joshua, Davis, Sydney, Olsen, Jaxon, Parsons, Matthew, Kann, Benjamin, Fagerlin, Angela, Watt, Melissa, Johnson, Skyler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214612/
https://www.ncbi.nlm.nih.gov/pubmed/35671074
http://dx.doi.org/10.2196/34183
_version_ 1784731056749936640
author Peterson, John
Wilson, Trevor
Gruhl, Joshua
Davis, Sydney
Olsen, Jaxon
Parsons, Matthew
Kann, Benjamin
Fagerlin, Angela
Watt, Melissa
Johnson, Skyler
author_facet Peterson, John
Wilson, Trevor
Gruhl, Joshua
Davis, Sydney
Olsen, Jaxon
Parsons, Matthew
Kann, Benjamin
Fagerlin, Angela
Watt, Melissa
Johnson, Skyler
author_sort Peterson, John
collection PubMed
description BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeking alternative therapies. METHODS: We used data from 649 campaigns posted on the website GoFundMe between 2011 and 2019 for beneficiaries with cancer pursuing alternative therapy. The data were analyzed using a mixed methods approach. Campaigns were categorized by timing of alternative therapy (either before or after experiencing conventional therapy). Qualitative analysis identified motivational themes. Chi-square tests of independence and Fisher tests (all 2-sided) determined significant differences in the presence of motivational themes between groups. RESULTS: The expression of concerns about the efficacy of conventional therapy was significantly more likely in campaigns for individuals who used conventional therapy first than in campaigns for individuals who started with alternative therapy (63.3% vs 41.7%; P<.001). Moreover, on comparing those who started with alternative therapy and those who switched from conventional to alternative therapy, those who started with alternative therapy more often expressed natural and holistic values (49.3% vs 27.0%; P<.001), expressed an unorthodox understanding of cancer (25.5% vs 16.4%; P=.004), referenced religious or spiritual beliefs (15.1% vs 8.9%; P=.01), perceived alternative treatment as efficacious (19.1% vs 10.2%; P=.001), and distrusted pharmaceutical companies (3.2% vs 0.5%; P=.04). CONCLUSIONS: Individuals sought treatments that reflected their values and beliefs, even if scientifically unfounded. Many individuals who reported prior conventional cancer therapy were motivated to pursue alternative treatments because they perceived the conventional treatments to be ineffective.
format Online
Article
Text
id pubmed-9214612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-92146122022-06-23 Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study Peterson, John Wilson, Trevor Gruhl, Joshua Davis, Sydney Olsen, Jaxon Parsons, Matthew Kann, Benjamin Fagerlin, Angela Watt, Melissa Johnson, Skyler JMIR Cancer Original Paper BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeking alternative therapies. METHODS: We used data from 649 campaigns posted on the website GoFundMe between 2011 and 2019 for beneficiaries with cancer pursuing alternative therapy. The data were analyzed using a mixed methods approach. Campaigns were categorized by timing of alternative therapy (either before or after experiencing conventional therapy). Qualitative analysis identified motivational themes. Chi-square tests of independence and Fisher tests (all 2-sided) determined significant differences in the presence of motivational themes between groups. RESULTS: The expression of concerns about the efficacy of conventional therapy was significantly more likely in campaigns for individuals who used conventional therapy first than in campaigns for individuals who started with alternative therapy (63.3% vs 41.7%; P<.001). Moreover, on comparing those who started with alternative therapy and those who switched from conventional to alternative therapy, those who started with alternative therapy more often expressed natural and holistic values (49.3% vs 27.0%; P<.001), expressed an unorthodox understanding of cancer (25.5% vs 16.4%; P=.004), referenced religious or spiritual beliefs (15.1% vs 8.9%; P=.01), perceived alternative treatment as efficacious (19.1% vs 10.2%; P=.001), and distrusted pharmaceutical companies (3.2% vs 0.5%; P=.04). CONCLUSIONS: Individuals sought treatments that reflected their values and beliefs, even if scientifically unfounded. Many individuals who reported prior conventional cancer therapy were motivated to pursue alternative treatments because they perceived the conventional treatments to be ineffective. JMIR Publications 2022-06-07 /pmc/articles/PMC9214612/ /pubmed/35671074 http://dx.doi.org/10.2196/34183 Text en ©John Peterson, Trevor Wilson, Joshua Gruhl, Sydney Davis, Jaxon Olsen, Matthew Parsons, Benjamin Kann, Angela Fagerlin, Melissa Watt, Skyler Johnson. Originally published in JMIR Cancer (https://cancer.jmir.org), 07.06.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on https://cancer.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Peterson, John
Wilson, Trevor
Gruhl, Joshua
Davis, Sydney
Olsen, Jaxon
Parsons, Matthew
Kann, Benjamin
Fagerlin, Angela
Watt, Melissa
Johnson, Skyler
Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title_full Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title_fullStr Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title_full_unstemmed Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title_short Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
title_sort timing and motivations for alternative cancer therapy with insights from a crowdfunding platform: cross-sectional mixed methods study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214612/
https://www.ncbi.nlm.nih.gov/pubmed/35671074
http://dx.doi.org/10.2196/34183
work_keys_str_mv AT petersonjohn timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT wilsontrevor timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT gruhljoshua timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT davissydney timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT olsenjaxon timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT parsonsmatthew timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT kannbenjamin timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT fagerlinangela timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT wattmelissa timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy
AT johnsonskyler timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy